For instance, Chen and his team performed a kinome-wide CRISPR/CAS9 screening in gastric cancer cell lines with fibroblast growth factor receptor 2 (FGFR2) amplification to identify kinases that lead to a sensitivity for AZD4547, a FGFR inhibitor, since not every gastric cancer cell line with FGFR2 amplification is sensitive to it. Here, FGFR2 is linked to gastric cancer.